Medicinal Cannabis Prescribing in Australia: An Analysis of Trends Over the First Five Years

A regulatory framework allowing legal access to medicinal cannabis (MC) products has operated in Australia since November 2016. MC prescribing by healthcare practitioners (HCPs) is primarily conducted through the Special Access Scheme - Category B (SAS-B) pathway, through which prescribers apply to...

Descripción completa

Detalles Bibliográficos
Autores principales: MacPhail, Sara L., Bedoya-Pérez, Miguel A., Cohen, Rhys, Kotsirilos, Vicki, McGregor, Iain S., Cairns, Elizabeth A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127064/
https://www.ncbi.nlm.nih.gov/pubmed/35620292
http://dx.doi.org/10.3389/fphar.2022.885655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127064/
https://www.ncbi.nlm.nih.gov/pubmed/35620292
http://dx.doi.org/10.3389/fphar.2022.885655

Ejemplares similares